Overview
Comparison of Three Methods of Hemoglobin Monitoring
Status:
Completed
Completed
Trial end date:
2011-10-01
2011-10-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study will further investigate the Masimo SpHb [FDA Approved] continuous non-invasive hemoglobin monitor in spine surgery patients. (See NCT00792597) We will investigate the effect of enhanced circulation to the finger (which will be attached to the sensor) following a local injection (digital block) of lidocaine (an FDA approved local anesthetic), and assess the accuracy of the SpHb reading as it relates to a standard laboratory hemoglobin value (tHb).Phase:
N/AAccepts Healthy Volunteers?
NoDetails
Lead Sponsor:
University of California, San FranciscoTreatments:
Lidocaine
Criteria
Inclusion Criteria:- Male or non-pregnant female 18 y/o or older
- ASA Classification 1, 2 or 3
- Scheduled to undergo spine or hip revision surgery
Exclusion Criteria:
- Pregnant or nursing
- Patients who in the study investigators clinical judgement would not be suitable for
research.